Patents by Inventor ANDRÉ VEILLETTE

ANDRÉ VEILLETTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF PREVENTING OR TREATING NON-HEMATOPOIETIC SLAMF7 POSITIVE AND SLAMF7 NEGATIVE CANCERS
    Publication number: 20210155691
    Abstract: A method for the prevention and/or treatment of a neoplastic disease comprising a solid tumor in a subject in need thereof, said method comprising administering an effective amount of a signal regulatory protein alpha (SIRPalpha)-cluster of differentiation 47 (CD47) checkpoint inhibitor or a composition comprising the inhibitor, and a pharmaceutically acceptable carrier, to a subject having solid tumor cells expressing signaling lymphocytic activation molecule family member 7 (SLAMF7) and CD47.
    Type: Application
    Filed: April 15, 2019
    Publication date: May 27, 2021
    Inventors: André VEILLETTE, Jun CHEN
  • METHODS OF PREVENTING OR TREATING SLAMF7 POSITIVE AND SLAMF7 NEGATIVE CANCERS
    Publication number: 20190135921
    Abstract: A method for the prevention and/or treatment of a neoplastic disease in a subject in need thereof, said method comprising administering an effective amount of a signal regulatory protein alpha (SIRPalpha)-cluster of differentiation 47 (CD47) checkpoint inhibitor or a composition comprising the inhibitor, and a pharmaceutically acceptable carrier, to a subject having neoplastic cells expressing signaling lymphocytic activation molecule family member 7 (SLAMF7) and CD47.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 9, 2019
    Inventors: ANDRÉ VEILLETTE, JUN CHEN
  • Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
    Publication number: 20100015654
    Abstract: The present invention relates to the identification EAT-2 and ERT as novel therapeutic targets for the modulation of innate immune cell functions. More particularly the present invention describes novel methods for modulating innate immune cells-mediated immune response, useful in the treatment of cancer, infectious diseases as well as autoimmune diseases.
    Type: Application
    Filed: May 15, 2006
    Publication date: January 21, 2010
    Applicant: Institut De Recherches Cliniques De Montreal/ I.R.C.M.
    Inventors: Andre Veillette, Romain Roncagalli